Evidence map›Paper›PMID 15134142›Full record

ArticleLipids2004

Beta-oxidation of 18:3n-3 in Atlantic salmon (Salmo salar L.) hepatocytes treated with different fatty acids.

Bente E Torstensen, Ingunn Stubhaug

Abstract read
PubMed Publisher
In one paragraph

Article in Lipids, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bente E TorstensenNational Institute of Nutrition and Seafood Research (NIFES), 5804 Bergen, Norway. bente.torstensen@nifes.no
Ingunn Stubhaug

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To study whether Atlantic salmon beta-oxidation was affected by dietary FA composition, an in vitro study with primary hepatocytes was undertaken. Isolated hepatocyte cultures were stimulated with either 16:0, 18:1n-9, 18:2n-6, 18:3n-3, 20:5n-3, or 22:6n-3 in triplicate for 24 h. In addition, a control was included where no FA stimulation was performed, also in triplicate. After stimulation, radiolabeled [1-14C] 18:3n-3 was added and the cells were incubated for 2 h at 20 degrees C. The cells were then harvested, and radioactivity was determined in the acid-soluble part of the cells and medium, i.e., the end products of the beta-oxidation pathway. Specific beta-oxidation activity was significantly higher in hepatocytes stimulated with 18:3n-3. Further, when taking into account the amount of radiolabeled [1-14C]18:3n-3 taken up by the cells--the relative amount of beta-oxidized [1-14C]18:3n-3 of the total FA taken up by the hepatocytes-no significant differences were found. Thus, the regulation of beta-oxidation activity in the primary Atlantic salmon hepatocytes seems to be at the level of FA uptake and transport into the cell. This in vitro study shows that the catabolism processes in salmon hepatocytes are affected by the FA available and probably already regulated at the level of FA uptake.

Indexed as

alpha-Linolenic AcidAnimalsCarbon RadioisotopesCells, CulturedDietary Fats, UnsaturatedFatty AcidsFatty Acids, Omega-3HepatocytesOxidation-ReductionSalmonalpha-Linolenic AcidCarbon RadioisotopesDietary Fats, UnsaturatedFatty AcidsFatty Acids, Omega-3

Identifiers

PMID15134142
OpenAlexW97892246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.